HOUGHTON MIFFLIN HARCOURT CO (HMHC) Fundamental Analysis & Valuation

NASDAQ:HMHC

21.03
+0.02 (+0.1%)
At close: Apr 6, 2022
21.12
+0.09 (+0.43%)
After Hours: 4/6/2022, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This HMHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall HMHC gets a fundamental rating of 2 out of 10. We evaluated HMHC against 75 industry peers in the Diversified Consumer Services industry. HMHC may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, HMHC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. HMHC Profitability Analysis

1.1 Basic Checks

  • In the past year HMHC was profitable.
HMHC Yearly Net Income VS EBIT VS OCF VS FCFHMHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 200M -200M -400M

1.2 Ratios

Industry RankSector Rank
ROA 10.82%
ROE 64.63%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HMHC Yearly ROA, ROE, ROICHMHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -100 -200 -300 -400 -500

1.3 Margins

Industry RankSector Rank
OM 5.41%
PM (TTM) 20.32%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HMHC Yearly Profit, Operating, Gross MarginsHMHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. HMHC Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for HMHC has been increased compared to 1 year ago.
  • Compared to 1 year ago, HMHC has an improved debt to assets ratio.
HMHC Yearly Shares OutstandingHMHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
HMHC Yearly Total Debt VS Total AssetsHMHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of -1.16, we must say that HMHC is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 0.96 indicates that HMHC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z -1.16
ROIC/WACCN/A
WACCN/A
HMHC Yearly LT Debt VS Equity VS FCFHMHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.39 indicates that HMHC should not have too much problems paying its short term obligations.
  • HMHC has a Quick Ratio of 1.18. This is a normal value and indicates that HMHC is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.18
HMHC Yearly Current Assets VS Current LiabilitesHMHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. HMHC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 104.02% over the past year.
  • HMHC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.80%.
  • HMHC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.05% yearly.
EPS 1Y (TTM)104.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-7.38%
Revenue growth 5Y-4.05%
Sales Q2Q%-12.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 67.54% on average over the next years. This is a very strong growth
  • HMHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.84% yearly.
EPS Next Y388.14%
EPS Next 2Y201.14%
EPS Next 3Y95.59%
EPS Next 5Y67.54%
Revenue Next Year3.98%
Revenue Next 2Y3.95%
Revenue Next 3Y3.37%
Revenue Next 5Y2.84%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HMHC Yearly Revenue VS EstimatesHMHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B
HMHC Yearly EPS VS EstimatesHMHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

2

4. HMHC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 300.43, the valuation of HMHC can be described as expensive.
  • HMHC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.03.
  • A Price/Forward Earnings ratio of 61.55 indicates a quite expensive valuation of HMHC.
  • When comparing the Price/Forward Earnings ratio of HMHC to the average of the S&P500 Index (25.11), we can say HMHC is valued expensively.
Industry RankSector Rank
PE 300.43
Fwd PE 61.55
HMHC Price Earnings VS Forward Price EarningsHMHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.11
HMHC Per share dataHMHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HMHC's earnings are expected to grow with 95.59% in the coming years.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y201.14%
EPS Next 3Y95.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HMHC Dividend Analysis

5.1 Amount

  • HMHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

HMHC Fundamentals: All Metrics, Ratios and Statistics

HOUGHTON MIFFLIN HARCOURT CO

NASDAQ:HMHC (4/6/2022, 8:00:02 PM)

After market: 21.12 +0.09 (+0.43%)

21.03

+0.02 (+0.1%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners1.13%
Inst Owner Change0%
Ins Owners0.59%
Ins Owner Change0%
Market Cap2.69B
Revenue(TTM)1.05B
Net Income(TTM)213.56M
Analysts45.71
Price Target21.42 (1.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 300.43
Fwd PE 61.55
P/S 2.56
P/FCF N/A
P/OCF N/A
P/B 8.13
P/tB N/A
EV/EBITDA 10.11
EPS(TTM)0.07
EY0.33%
EPS(NY)0.34
Fwd EY1.62%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.23
BVpS2.59
TBVpSN/A
PEG (NY)0.77
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 10.82%
ROE 64.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 5.41%
PM (TTM) 20.32%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.18
Altman-Z -1.16
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)104.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
EPS Next Y388.14%
EPS Next 2Y201.14%
EPS Next 3Y95.59%
EPS Next 5Y67.54%
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-7.38%
Revenue growth 5Y-4.05%
Sales Q2Q%-12.18%
Revenue Next Year3.98%
Revenue Next 2Y3.95%
Revenue Next 3Y3.37%
Revenue Next 5Y2.84%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

HOUGHTON MIFFLIN HARCOURT CO / HMHC FAQ

What is the ChartMill fundamental rating of HOUGHTON MIFFLIN HARCOURT CO (HMHC) stock?

ChartMill assigns a fundamental rating of 6 / 10 to HMHC.


What is the valuation status of HOUGHTON MIFFLIN HARCOURT CO (HMHC) stock?

ChartMill assigns a valuation rating of 3 / 10 to HOUGHTON MIFFLIN HARCOURT CO (HMHC). This can be considered as Overvalued.


How profitable is HOUGHTON MIFFLIN HARCOURT CO (HMHC) stock?

HOUGHTON MIFFLIN HARCOURT CO (HMHC) has a profitability rating of 10 / 10.


What is the valuation of HOUGHTON MIFFLIN HARCOURT CO based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HOUGHTON MIFFLIN HARCOURT CO (HMHC) is 300.43 and the Price/Book (PB) ratio is 8.13.


Can you provide the dividend sustainability for HMHC stock?

The dividend rating of HOUGHTON MIFFLIN HARCOURT CO (HMHC) is 0 / 10 and the dividend payout ratio is 0%.